March 12 (SeeNews) - North Macedonian drug maker Replek [MSE:REPL] said that its consolidated net profit fell to 100 million denars ($1.8 million/1.6 million euro) in 2018 from 129.2 million denars the year before.
The company's sales revenue grew to 974.7 million denars last year from 955.2 million denars in 2017, Replek said in a bourse filing on Monday.
Expenses for materials increased to 398.8 million denars in 2018 from 366.2 million denars a year earlier, while personnel expenses rose to 265 million denars from 230.4 million denars.
(1 euro = 61.52 denars)